Cancer study identifies why patients do not respond to personalized immune therapy, sparking new vaccine

Updated on: October 06,2025 0

Cancer study identifies why patients do not respond to personalized immune therapy, sparking new vaccine

Updated on:October 06,2025 0

How metabolic chatter between cells undermines anti-tumor immunity

Updated on: August 14,2025 0

How metabolic chatter between cells undermines anti-tumor immunity

Updated on:August 14,2025 0

NIH research funding drops $1B under Trump administration

Updated on: March 29,2025 0

NIH research funding drops $1B under Trump administration

Updated on:March 29,2025 0

Over half of doctors surveyed would consider assisted dying if they had advanced cancer or Alzheimer's disease

Updated on: July 10,2025 0

Over half of doctors surveyed would consider assisted dying if they had advanced cancer or Alzheimer's disease

Updated on:July 10,2025 0

Cutting-edge cancer treatment isn't known by most Americans

Updated on: May 20,2025 0

Cutting-edge cancer treatment isn't known by most Americans

Updated on:May 20,2025 0

Digging into a decades-old hepatitis B mystery suggests a new potential treatment

Updated on: March 29,2025 0

Digging into a decades-old hepatitis B mystery suggests a new potential treatment

Updated on:March 29,2025 0

How to keep your prostate healthy and lower your risk of developing serious problems

Updated on: October 06,2025 0

How to keep your prostate healthy and lower your risk of developing serious problems

Updated on:October 06,2025 0

Surprising drug combination cuts alcohol use and lessens nausea in clinical trial

Updated on: July 09,2025 0

Surprising drug combination cuts alcohol use and lessens nausea in clinical trial

Updated on:July 09,2025 0

Ivermectin, hydroxychloroquine prescriptions during the COVID-19 pandemic soared far above pre-pandemic levels

Updated on: March 27,2025 0

Ivermectin, hydroxychloroquine prescriptions during the COVID-19 pandemic soared far above pre-pandemic levels

Updated on:March 27,2025 0

FDA approves Romvimza for tenosynovial giant cell tumor (TGCT)

Updated on: March 28,2025 0

FDA approves Romvimza for tenosynovial giant cell tumor (TGCT)

Updated on:March 28,2025 0